44.74
0.01%
+0.0003
Usana Health Sciences Inc stock is currently priced at $44.74, with a 24-hour trading volume of 32,150.
It has seen a +0.01% increased in the last 24 hours and a -4.27% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $44.76 pivot point. If it approaches the $44.47 support level, significant changes may occur.
Previous Close:
$44.74
Open:
$44.29
24h Volume:
32,150
Market Cap:
$854.76M
Revenue:
$921.01M
Net Income/Loss:
$63.79M
P/E Ratio:
14.49
EPS:
3.0879
Net Cash Flow:
$56.15M
1W Performance:
-1.77%
1M Performance:
-4.27%
6M Performance:
-1.23%
1Y Performance:
-32.61%
Usana Health Sciences Inc Stock (USNA) Company Profile
Name
Usana Health Sciences Inc
Sector
Industry
Phone
801-954-7100
Address
3838 West Parkway Boulevard, Salt Lake City, UT
Usana Health Sciences Inc Stock (USNA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-23-23 | Initiated | Sidoti | Buy |
Jul-07-22 | Downgrade | Jefferies | Hold → Underperform |
Apr-14-22 | Initiated | DA Davidson | Neutral |
Dec-17-20 | Initiated | ROTH Capital | Buy |
Aug-22-19 | Initiated | Jefferies | Hold |
Apr-16-19 | Initiated | Tigress Financial | Buy |
Oct-25-18 | Upgrade | Sidoti | Neutral → Buy |
Oct-24-18 | Upgrade | Pivotal Research Group | Hold → Buy |
Apr-23-18 | Downgrade | Pivotal Research Group | Buy → Hold |
Feb-07-18 | Reiterated | Pivotal Research Group | Buy |
Jan-24-18 | Downgrade | Sidoti | Buy → Neutral |
Oct-25-17 | Reiterated | Pivotal Research Group | Buy |
Jul-26-17 | Reiterated | Pivotal Research Group | Buy |
May-03-17 | Upgrade | Pivotal Research Group | Hold → Buy |
May-01-17 | Downgrade | Pivotal Research Group | Buy → Hold |
Feb-08-17 | Reiterated | Pivotal Research Group | Buy |
Jul-28-16 | Reiterated | DA Davidson | Neutral |
Feb-10-16 | Downgrade | DA Davidson | Buy → Neutral |
Oct-16-15 | Upgrade | Sidoti | Neutral → Buy |
Sep-16-15 | Upgrade | DA Davidson | Neutral → Buy |
Aug-06-15 | Downgrade | DA Davidson | Buy → Neutral |
Aug-05-15 | Upgrade | Pivotal Research Group | Hold → Buy |
Jun-26-15 | Initiated | DA Davidson | Buy |
View All
Usana Health Sciences Inc Stock (USNA) Latest News
USNA or STVN: Which Is the Better Value Stock Right Now?
Zacks Investment Research
USANA Health Sciences (USNA) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research
Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains?
Zacks Investment Research
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
Zacks Investment Research
Usana Health Sciences Inc Stock (USNA) Financials Data
Usana Health Sciences Inc (USNA) Revenue 2024
USNA reported a revenue (TTM) of $921.01 million for the quarter ending December 31, 2023, a -7.77% decline year-over-year.
Usana Health Sciences Inc (USNA) Net Income 2024
USNA net income (TTM) was $63.79 million for the quarter ending December 31, 2023, a -8.02% decrease year-over-year.
Usana Health Sciences Inc (USNA) Cash Flow 2024
USNA recorded a free cash flow (TTM) of $56.15 million for the quarter ending December 31, 2023, a -39.95% decrease year-over-year.
Usana Health Sciences Inc (USNA) Earnings per Share 2024
USNA earnings per share (TTM) was $3.30 for the quarter ending December 31, 2023, a -8.08% decline year-over-year.
Usana Health Sciences Inc Stock (USNA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
FULLER GILBERT A | Director |
May 07 '24 |
Sale |
44.59 |
490 |
21,849 |
0 |
Macuga Daniel A. | CHIEF COMMUNICATIONS OFFICER |
May 02 '24 |
Sale |
47.14 |
3,791 |
178,717 |
0 |
WOOD TIMOTHY E | Director |
Apr 24 '24 |
Option Exercise |
0.00 |
490 |
0 |
5,252 |
Winssinger Frederic J | Director |
Apr 24 '24 |
Option Exercise |
0.00 |
490 |
0 |
3,174 |
Nixon J Scott | Director |
Apr 24 '24 |
Option Exercise |
0.00 |
490 |
0 |
2,886 |
Pelosi Peggie | Director |
Apr 24 '24 |
Option Exercise |
0.00 |
490 |
0 |
3,628 |
FULLER GILBERT A | Director |
Apr 24 '24 |
Option Exercise |
0.00 |
490 |
0 |
490 |
Fleming John Turman | Director |
Apr 24 '24 |
Option Exercise |
0.00 |
490 |
0 |
3,503 |
Ding Xia | Director |
Apr 24 '24 |
Option Exercise |
0.00 |
490 |
0 |
2,646 |
Guest Kevin | EXEC. CHAIRMAN OF THE BOARD |
Mar 11 '24 |
Sale |
49.00 |
11,011 |
539,539 |
10,491 |
About Usana Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensébeautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Cap:
|
Volume (24h):